Carboplatin ‘Promising Treatment Option’ for Triple-Negative Breast Cancer

Carboplatin improves the pathological complete response rate in women with stages II-III, triple-negative breast cancer. 

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.